Description
রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন
Indications:
-
Type 2 Diabetes Mellitus
-
Adjunct to diet and exercise to improve glycemic control
-
Especially beneficial for overweight patients and those with cardiovascular risk
Pharmacology:
-
Dapagliflozin: A sodium-glucose co-transporter 2 (SGLT2) inhibitor that reduces blood glucose by promoting urinary glucose excretion.
-
Metformin: A biguanide that decreases hepatic glucose production and improves insulin sensitivity, thus lowering blood sugar levels.
Dosage:
-
Typically 1 tablet daily or as prescribed by the physician
-
Dose adjustment may be needed based on blood glucose levels and tolerance
Administration:
-
Oral administration with food to reduce gastrointestinal side effects
-
Swallow whole with sufficient water
Interaction:
-
Caution with other hypoglycemic agents (e.g., insulin, sulfonylureas) due to risk of hypoglycemia
-
Potential interaction with diuretics, ACE inhibitors, and alcohol
Contraindications:
-
Type 1 Diabetes
-
Diabetic ketoacidosis
-
Severe renal impairment (eGFR <30 mL/min/1.73 m²)
-
Hypersensitivity to any component
Side Effects:
-
Common: Genital infections, urinary tract infections, gastrointestinal upset, headache
-
Rare: Lactic acidosis (Metformin), hypotension, dehydration
Pregnancy & Lactation:
-
Should only be used if clearly needed and prescribed by a physician
-
Not recommended during breastfeeding unless advised by a doctor
Precautions & Warnings:
-
Monitor renal function regularly
-
Ensure adequate hydration
-
Discontinue before major surgery or radiologic procedures involving contrast
Therapeutic Class:
Combination Oral Hypoglycemic Agents (SGLT2 Inhibitor + Biguanide)
Storage Conditions:
Store below 30°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.
 100 IU.jpg)
 100 IU.jpg)
 350ML.jpg)
 20025 20025.jpg)
 350ML.jpg)
.jpg)
 60 ML.jpg)
.jpg)
 30PCS.jpg)
 400MG.jpg)
 10025 100 MG 25 MG.jpg)
 15050160.jpg)
Change Language